M. Koga et al., RELATIONSHIP BETWEEN CIRCULATING VASCULAR CELL-ADHESION MOLECULE-1 AND MICROVASCULAR COMPLICATIONS IN TYPE-2 DIABETES-MELLITUS, Diabetic medicine, 15(8), 1998, pp. 661-667
The soluble form of the vascular cell adhesion molecule-1 (VCAM-1) is
detectable in human sera and is elevated in diabetic patients, with un
known clinical significance. In the present study, the relationship be
tween serum soluble VCAM-1 and diabetic microvascular complications (r
etinopathy, nephropathy, and neuropathy) was evaluated in 95 Japanese
patients with Type 2 diabetes mellitus (DM). Serum soluble VCAM-1 conc
entration was higher in patients with more advanced stages of retinopa
thy as well as nephropathy. There was a significant correlation betwee
n soluble VCAM-1 and log,, (urinary albumin excretion) in 69 patients
with normal serum creatinine levels (r = 0.51, p<0.0001) and a signifi
cant correlation between soluble VCAM-1 and log,, (serum creatinine) i
n all the patients (r = 0.83, p<0.0001). Soluble VCAM-1 concentration
was also elevated in patients with neuropathy. There was a significant
correlation between soluble VCAM-1 concentration and the number of mi
crovascular complications (r = 0.59, p<0.0001). However, multivariate
regression analysis revealed that only diabetic nephropathy, was assoc
iated with the soluble VCAM-1 concentration. The elevation of circulat
ing VCAM-1 level in diabetic nephropathy may result from underlying sy
stemic endothelial dysfunction, increased VCAM-1 production in damaged
renal tubular or glomerular epithelial cells and/or decreased renal c
learance of this molecule, depending on the stage of nephropathy. (C)
1998 John Wiley & Sons, Ltd.